Vitamin K (Menaquinone-4) Metabolism in Liver Disease

References

• Stenflo J, Fernlund P, Egen W, Roepstorff P. Vitamin K dependent modifications glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974; 71: 2730–2733
   PubMed Web of Science ®Google Scholar
• Suttie J W. Recent advances in hepatic vitamin K metabolism and function. Hepatology 1987; 7: 367–376
   PubMed Web of Science ®Google Scholar
• Roberts H R, Cederbaum A I. The liver and blood coagulation: physiology and pathology. Gastroenterology 1972; 63: 297–320
   PubMed Web of Science ®Google Scholar
• Suttie J W. Vitamin K-dependent carboxylase. Ann Res Biochem 1985; 54: 459–477
   PubMed Web of Science ®Google Scholar
• Chisholm M. Haematological disorders in liver disease. Liver and biliary disease, R Wright. Saunders, Philadelphia 1979; 159–181
   Google Scholar
• Munoz S J, Maddrey W C. Major complications of acute and chronic liver disease. Gastroenterol Clin North Am 1988; 17: 265–287
   PubMedGoogle Scholar
• Olson R E, Vitamin K. Modern nutrition in health and disease, R S Goodhart, M E Shils. Lea & Febiger, Philadelphia 1980; 170–180
   Google Scholar
• Savage D, Lindenbaum J. Clinical and experimental human vitamin K deficiency. Nutrition in hematology, J Lindenbaum. Churchill Livingstone, New York 1983; 271–320
   Google Scholar
• Caldwell P T, Ren P, Bell R G. Warfarin and metabolism of vitamin K1. Biochem Pharmacol 1974; 23: 3353–3362
   PubMedGoogle Scholar
• Shearer M J, McBurney A, Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm 1974; 32: 513–542
   PubMedGoogle Scholar
• Carlisle D M, Blaschke T F. Vitamin K1, vitamin K1 epoxide and warfarin interrelationships in the dog. Biochem Pharmacol 1981; 30: 2931–2936
   PubMedGoogle Scholar
• Bechtold H, Andrassy K, Jähnchen E, et al. Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost 1984; 51: 358–361
   PubMed Web of Science ®Google Scholar
• Creedon K A, Suttie J W. Effect of N-methyl-thio-tetrazole on vitamin K epoxide reductase. Thromb Res 1986; 44: 147–153
   PubMedGoogle Scholar
• Shearer M J, Bechtold H, Andrassay K, et al. Mechanism of cephalosporin-induced hypoprothrom-binemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 1988; 28: 88–95
   PubMed Web of Science ®Google Scholar
• Shearer M J, Maliinson C N, Webster G R, Barkhan P. Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K1 in man. Br J Haematol 1972; 22: 579–588
   PubMedGoogle Scholar
• Bechtold H, Trenk D, Meinertz T, Rowland M, Jähnchen E. Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man. Br J Clin Pharmacol 1983; 16: 683–689
   PubMedGoogle Scholar
• Shino M, Yamashiro T, Yamada K, et al. Determination of menaquinone-4 in plasma after administration of menaquinone-4 dosage forms in healthy human subjects. Yakugaku Zasshi 1982; 102: 651–658
   PubMedGoogle Scholar
• Usui Y, Nishimura N, Kobayashi N, Okanoue T, Kimoto M, Ozawa K. Measurement of vitamin K in human liver by gradient high-performance liquid chromatography using fluorimetric detection with platinum-black catalytic reduction and fluorimetric detection. J Chromatogr 1989; 489: 291–301
   PubMed Web of Science ®Google Scholar
• Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990; 51: 846–852
   PubMed Web of Science ®Google Scholar
• Hildebrandt E, Suttie J W. Indirect inhibition of vitamin K epoxide reduction by salicylate. J Pharm Pharmacol 1983; 36: 586–591
   Google Scholar
• Hirauchi K, Sakano T, Nagaoka T, Morimoto A. Simultaneous determination of vitamin K1 vitamin K1 2,3-epoxide and menaquinone-4 in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr 1988; 430: 21–29
   PubMedGoogle Scholar
• Laurell C B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45–52
   PubMed Web of Science ®Google Scholar
• Margaritella P, Deutsch E. Clinical use of a method for the determination of factor VII by a chromo-genic substrate. Thromb Res 1981; 21: 585–591
   PubMed Web of Science ®Google Scholar
• Shimamoto M, Yoshimura T, Kimura N, et al. Protein C in human plasma determined by homogenous enzyme immunoassay with use of a centrifugal analyzer. Clin Chem 1988; 34: 1834–1838
   PubMed Web of Science ®Google Scholar
• Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 43–57
   PubMed Web of Science ®Google Scholar
• Mori K, Ozawa K, Yamamoto Y, et al. Response of hepatic mitochondrial redox state to oral glucose load: redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 1990; 211: 438–446
   PubMedGoogle Scholar
• Yamaoka Y, Shimahara Y, Nakatani T, et al. Clinical role of blood ketone body ratio as an indicatorevaluating hepatic tolerance for portal triad cross-clamping in cirrhotic liver resection. Surg Res Comm 1988; 3: 87–93
   Google Scholar
• Ozawa K, Aoyama H, Yasuda K, et al. Metabolic abnormalities associated with postoperative organ failure: a redox theory. Arch Surg 1983; 118: 1245–1251
   PubMed Web of Science ®Google Scholar
• Corrigan J J, Jr. Vitamin K dependent proteins. Adv Pediatr 1981; 28: 57
   PubMedGoogle Scholar
• Liebman H A, Furie B C, Tong M J, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. n. Engl J Med 1984; 310: 1427–1431
   PubMed Web of Science ®Google Scholar
• Blanchard R A, Furie B C, Jorgensen M, Kruger S F, Furie B. Acquired vitamin K-dependent carb-oxylation deficiency in liver disease. n. Engl J Med 1981; 305: 242–248
   PubMed Web of Science ®Google Scholar
• Blanchard R A, Furie B C, Jorgensen M, Kruger S F, Furie B. Correspondence. Acquired vitamin K-dependent carboxylation deficiency in liver disease. n. Engl J Med 1981; 305: 1285–1286
   PubMedGoogle Scholar
• Green G, Poller L, Thomson J M, Dymock I W. Factor VII as a hepatocellular synthetic function in liver disease. J Clin Pathol 1976; 29: 971–975
   PubMedGoogle Scholar
• Okabe K. Vitamin K-dependent coagulation factors in hepatobiliary diseases. Acta Haematol Jpn 1982; 45: 834–839
   PubMedGoogle Scholar
• Kelly D A, O'Brien F J, Hutton R A, Tuddenham E GD, Summerfield J A, Sherlock S. The effect of liver disease on factor V, VIII and protein C. Br J Haematol 1985; 61: 541–548
   PubMed Web of Science ®Google Scholar